| 1. |
- Szymanski, J. J., et al.
(författare)
-
A study of the decay mu –> e gamma by the MEGA experiment
- 1996
-
Ingår i: Proceedings, 9th Meeting, DPF'96, Minneapolis, USA, August 11-15, 1996. Vol. 1, 2.. ; , s. 1450-1452
-
Konferensbidrag (refereegranskat)
|
|
| 2. |
- Jiang, Z. K, et al.
(författare)
-
Lifetimes of Rydberg Levels In the Perturbed 6snp P-1,3(1) Series of Ybi
- 1995
-
Ingår i: Physics Letters. Section A: General, Atomic and Solid State Physics. - : Elsevier BV. - 0375-9601. ; 204:1, s. 49-53
-
Tidskriftsartikel (refereegranskat)abstract
- Using two methods: (1) three-step excitation and (2) single UV photon excitation in an atomic beam with direct observation of the decay of the fluorescence light, we have measured the lifetimes of the Rydberg levels of YbI belonging to the perturbed series 6snp J = 1 levels. The measured values have been interpreted by the multichannel quantum defect theory (MQDT).
|
|
| 3. |
- Liu, Y X, et al.
(författare)
-
Prolactin delays gonadotrophin-induced ovulation and down-regulates expression of plasminogen-activator system in ovary.
- 1997
-
Ingår i: Human Reproduction. - 0268-1161 .- 1460-2350. ; 12:12, s. 2748-55
-
Tidskriftsartikel (refereegranskat)abstract
- This study was conducted to determine whether prolactin (PRL) suppresses gonadotrophin-induced ovulation and disturbs the co-ordinated gene expression of tissue type plasminogen activator (tPA) and plasminogen activator inhibitor type-1 (PAI-1) in rat ovary. Immature female rats were injected with 10 IU pregnant mare's serum gonadotrophin to stimulate follicle growth, and 48 h received different doses of prolactin followed by 7 IU human chorionic gonadotrophin (HCG). The oviducts were examined for the presence of ova, and the amounts of tPA and PAI-1 mRNA present in the ovary were measured at various times after the hormone treatment. PRL had no significant effect on ovarian weight but caused a dose-dependent decrease in ovulation number. In the control animals receiving HCG alone, 13.3 +/- 1.3 (mean +/- SEM) ova/oviduct were found; while in animals receiving HCG plus 50, 100 or 200 microg PRL, the ovulation number was dose-dependently suppressed by 53.6, 66.9 and 76% respectively at 18 h after treatment. PRL suppression of HCG-induced ovulation was time-dependent. By 24 h after treatment, the number of ova in the oviducts in HCG- and HCG plus PRL-treated groups was not significantly different. PRL also suppressed HCG-induced tPA gene expression in a dose- and time-dependent manner. At all time points examined, tPA mRNA content of whole ovaries and granulosa cells (GC) in PRL-treated groups was lower than in the HCG-treated controls. The activities of PAI-1 in ovarian extracellular fluid (OEF) and PAI-1 mRNA in the theca-interstitial cells (TI) in the PRL-treated groups were higher than in the HCG-treated controls. The highest stimulation by PRL of PAI-1 activity in OEF and of PAI-1 mRNA in TI was observed at 9 h and 6 h after HCG treatment respectively. The localization of tPA and PAI-1 antigens in the ovaries was consistent with changes in the mRNA and activity levels. These data suggest that PRL temporarily delays, but does not completely inhibit, HCG-induced ovulation, which may be caused by a suppression of PA-mediated proteolysis.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
